CAH Stock Analysis: Buy, Sell, or Hold?
CAH - Cardinal Health, Inc.
$227.18
4.44 (1.99%)
▲
5d:
+0.34%
30d:
+13.24%
90d:
+10.07%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Smart Money Distribution
None View Scanner →
Strength: 7.6/10
Get Alerted When CAH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CAH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CAH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$324.60
Based on 7.7% avg growth
INTRINSIC VALUE TODAY
$201.55
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CAH is currently trading at $227.18, which is considered extended relative to its 30-day fair value range of $195.50 to $218.64. The stock's valuation (Forward PE: 18.6) is in line with its historical norms (18.7). Remarkably, the market is currently pricing in an annual earnings decline of 0.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CAH is in a downtrend. The price is approaching resistance at $229.78. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CAH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $245.27 (+10.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CAH is in a downtrend. The price is approaching resistance at $229.78. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CAH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $245.27 (+10.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$195.50 -
$218.64
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
59.5%
Protect Your Profits
CAH is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($245.27)
Trading Range Analysis
30-Day Trading Range
$195.50 -
$218.64
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$202.04
Resistance Level
$229.78
Current Trend
Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.57
Wall Street Target
$245.27
(+10.1%)
Revenue Growth (YoY)
11.0%
Earnings Growth (YoY)
-19.5%
Profit Margin
0.6%
Valuation Discount vs History
-0.3% cheaper
PE vs Historical
18.6 vs 18.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.3%
(market-implied from PE analysis)
1-Year Target
$222.07
(0%)
2-Year Target
$221.41
(-1%)
3-Year Target
$220.74
(-1%)
3-Yr Target (if PE normalizes)
(PE: 19→19)
$222.33
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 11.4%)
$361.33
(+62%)
Base:
(SPY PE: 18.6, Growth: 11.4%)
$308.02
(+38%)
Bear:
(PE: 15.8, Growth: 11.4%)
$261.82
(+18%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (34x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 33.91 | Current EPS (TTM): $6.54
Bull Case
$447.49
(+101%)
Analyst growth 83.4%, PE expands to 37.3
Base Case
$406.81
(+83%)
Market implied 83.4%, PE stable at 33.9
Bear Case
$150.80
(-32%)
Severe decline -20.0%, PE contracts to 28.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.6 to 18.7
Stabilization Target:
$224.34
(+0.7%)
PE Expansion Potential:
+0.7%
Share & Embed Analysis
Last updated: June 23, 2026 2:33 PM ET
Data refreshes hourly during market hours. Next update: 3:33 PM
Data refreshes hourly during market hours. Next update: 3:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CAH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-02-05
Ro Khanna
SELL
2026-01-23
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$941 | 59 HOLD |
|
COR
Cencora Inc. |
STRONG BUY
14 analysts |
$351 | 62 BUY |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$88 | 64 BUY |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 53 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 53 HOLD |
Advanced CAH Option Strategies
Professional options setups generated by AI based on today's CAH price and gamma walls.
